2023 News

DCTD’s Translational Research Program (TRP) Announces Fiscal Year 2023 SPORE Grantees

Date: December 11, 2023
Source: DCTD News

Summary and Recordings Available from the NCI Cancer Diagnosis Program Workshop: ctDNA in Cancer Treatment and Clinical Care

Date: October 17, 2023
Source: DCTD Events

The Dog Oncology Grant Supplement (DOGS) Program

Date: October 12, 2023
Source: DCTD News

2023 NCI Drug Development Workshop II: Specialized Topics in Preclinical Development of Small Molecule Cancer Drugs

Date: October 10, 2023
Source: DCTD Meetings

Cancer, Aging, and Comorbidities Workshop; January 25-July 14, 2023

Date: August 28, 2023
Source: DCTD Meetings

NCI’s ComboMATCH initiative will test new drug combinations guided by tumor biology

Date: June 1, 2023
Source: NCI Press Release

DTP provides grants services, and resources to facilitate the discovery and development of new cancer therapeutic agents

Date: June 13, 2023
Source: DTP Website

Blinatumomab increases survival for infants with an aggressive type of ALL

Date: June 8, 2023
Source: NCI Cancer Currents

Drug regimen boosts survival of people with advanced colorectal cancer

Date: May 24, 2023
Source: NCI Cancer Currents

Rare melanoma very likely to respond to treatment with pembrolizumab

Date: May 5, 2023
Source: NCI Cancer Currents

Nirogacestat may offer hope to people with desmoid tumors

Date: May 1, 2023
Source: NCI Cancer Currents

Transforming cancer clinical trials for better, fast results

Date: May 1, 2023
Source: NCI Cancer Currents

Immunotherapy’s role in treating endometrial cancer expected to grow

Date: April 12, 2023
Source: NCI Cancer Currents

Liquid biopsies on the horizon for children with solid cancers

Date: April 11, 2023
Source: NCI Cancer Currents

Schedule of DCTD Presentations at ASCO 2023

Posted May 30, 2023
Source: DCTD News

The Cancer Imaging Program Convenes the Co-Clinical Imaging Research Resource Program (CIRP) Annual Virtual Meeting 2023

Posted May 23, 2023
Source: DCTD Meetings

Pragmatica-Lung Study, a streamlined model for future cancer clinical trials, begins enrolling patients

Posted April 12, 2023
Source: NCI Press Release

2023 American Association for Cancer Research Annual Meeting; Schedule of DCTD Presentations

Posted March 29, 2023
Source: DCTD News

NCI Webinar Series: Novel Chemical Approaches for Targeting Fusion Oncoproteins; August 19 - October 21, 2022

Posted March 27, 2023
Source: DCTD Meetings

Preventing Resistance to Cancer Targeted Therapies

Posted March 17, 2023
Source: NCI Cancer Currents Blog

Tucatinib Approved for HER2-Positive Colorectal Cancer

Posted February 10, 2023
Source: NCI Cancer Currents Blog

Blinatumomab Extends Life for People with ALL in Remission

Posted January 25, 2023
Source: NCI Cancer Currents Blog

Kisqali Plus Hormone Therapy for Metastatic Breast Cancer

Posted January 11, 2023
Source: NCI Cancer Currents Blog